Codexis (CDXS) Receivables - Net (2010 - 2026)
Codexis (CDXS) recorded quarterly Receivables - Net of $8.0 million in Q1 2026, down 8.34% quarter-over-quarter from $8.8 million in Q4 2025, and up 24.6% on a YoY basis from $6.4 million in Q1 2025.
Codexis (CDXS) Receivables - Net (2010 - 2026) Analysis & Trends
Codexis' Receivables - Net history runs 17 years deep, the most recent figure standing at $8.0 million for Q1 2026.
- In Q1 2026, Receivables - Net rose 24.6% year-over-year to $8.0 million; the TTM figure through Mar 2026 stood at $8.0 million (up 24.6% YoY), while the FY2025 annual figure was $8.8 million, down 53.63% from the prior year.
- Receivables - Net was $8.0 million for Q1 2026 at Codexis, down from $8.8 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $48.9 million in Q2 2022 to a low of $6.4 million in Q1 2025.
- Historically, Receivables - Net has averaged $18.0 million across 5 years, with a median of $14.2 million in 2024.
- The sharpest annual moves came in 2022 and 2023: Receivables - Net jumped 288.07% in 2022, then sank 82.0% in 2023.
- A 5-year view of Receivables - Net shows it stood at $31.9 million in 2022, then sank by 37.54% to $19.9 million in 2023, then fell by 5.24% to $18.9 million in 2024, then plunged by 53.63% to $8.8 million in 2025, then declined by 8.34% to $8.0 million in 2026.
- The last three Receivables - Net figures came in at $8.0 million (Q1 2026), $8.8 million (Q4 2025), and $9.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - |
| 10 | Codexis | 236.00 Mn | 170.86 Mn | 13.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.03 Mn |
| Mar 31, 2026 | 8.03 Mn |
| Dec 31, 2025 | 8.76 Mn |
| Dec 31, 2025 | 8.76 Mn |
| Sep 30, 2025 | 9.73 Mn |
| Sep 30, 2025 | 9.73 Mn |
| Jun 30, 2025 | 12.27 Mn |
| Jun 30, 2025 | 12.27 Mn |
| Mar 31, 2025 | 6.44 Mn |
| Mar 31, 2025 | 6.44 Mn |
| Dec 31, 2024 | 18.88 Mn |
| Dec 31, 2024 | 18.88 Mn |
| Sep 30, 2024 | 16.54 Mn |
| Sep 30, 2024 | 16.54 Mn |
| Jun 30, 2024 | 12.39 Mn |
| Jun 30, 2024 | 12.39 Mn |
| Mar 31, 2024 | 14.21 Mn |
| Mar 31, 2024 | 14.21 Mn |
| Dec 31, 2023 | 19.93 Mn |
| Dec 31, 2023 | 19.93 Mn |